Thursday, February 21, 2019 5:27:16 AM
It is irrevocably agreed by all the Sellers of BioCann, shareholders representing 51% of the
existing shares of GNCC Common Stock and the GNCC Directors that no Reverse Split of
GNCC stock shall be contemplated by nor approved by any GNCC Director whatsoever and for
a period of not less than 18 (eighteen) months from the Effective Date of this Agreement. This is
effectively “cast in stone” as the Current Directors and those voting in favor of this transaction
would have not approved this acquisition in the absence of this provision. Given the shares of
restricted Common Stock being issued to the Sellers of BioCann, any Reverse Split of the
Common Stock would be contrary to their personal financial interests...
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM